Opening Date
|
August 04, 2021
|
Closing Date
|
August 06, 2021
|
Face Value
|
Rs. 5 per equity share
|
IPO Price Band
|
Rs. 448 to 460 per equity share
|
Minimum Order Quantity
|
30 equity shares
|
Issue Size
|
Rs. 401.54 crores
|
The month of August, 2021 is off to a good start with as many as four mainboard IPOs in the fray. One of them is from a company operating in the pharmaceutical space - Windlas Biotech. Here’s a quick look at the key Windlas Biotech IPO details.
Windlas Biotech Limited is a company that was incorporated in the year 2001. Since its inception, the company has been involved in the manufacturing of chemical formulations used in the pharmaceutical industry. It has been doing it under the contract development and manufacturing model and has made a name for itself in this short span of time.
The company’s business can be split into three primary divisions - export manufacturing, domestic trade of generics and over-the-counter (OTC) products, and contract development and manufacturing products and services. Some of the key clients of the company include some big-name pharmaceutical companies such as Sanofi India, Pfizer, Cadila Healthcare, Eris Lifesciences, and more.
- Windlas Biotech IPO details
Now that you’ve been acquainted with the company, let’s take a look at some of the key details of the upcoming IPO 2023such as the Windlas Biotech IPO date and the Windlas Biotech IPO share price, among others.
The upcoming IPO of the company is scheduled to hit the market on August 04, 2021, with the public issue coming to a close two days later on August 06, 2021.
- Windlas Biotech IPO issue size
The total size of the latest IPO of Windlas Biotech is around Rs. 401.54 crores, with the fresh issue component accounting for around Rs. 165 crores. The remaining amount of Rs. 236.54 crores would be from an Offer for Sale (OFS) from the promoters of the company, where around 51,42,067 equity shares are being planned to be sold by them.
- Windlas Biotech IPO share price
The company has fixed the share price band of its upcoming IPO from Rs. 448 to Rs. 460 per equity share. Considering the fact that the face value of the company’s shares is just Rs. 5 per equity share, the premium is quite hefty.
- Windlas Biotech IPO listing
The company is looking to list its shares on both the exchanges of the country - the BSE as well as the NSE.
- Windlas Biotech IPO objectives
In addition to using the funds for purchasing equipment for expanding its manufacturing facility in Dehradun, the company is also looking to use them for the following purposes.
- For financing working capital requirements
- For repayment of loans and other borrowings
- For general corporate purposes
Conclusion
Does this latest IPO seem like something that you would be interested in investing? If so, then it is a good idea to open a demat account forthwith since you can’t invest in the stock market without one. Visit the webpage of Motilal Oswal to know more about how to open a demat account online for free.
Before commencing online trading, always remember to open a demat account and trading account with a trusted and reliable financial partner.
If you already have an existing account, you can start your online trading and invest in the upcoming IPO's.
With a plethora of companies coming forward with their own IPOs in quick succession, you can keep a track of all the upcoming IPOs by regularly following our IPO calendar.
Related IPO Articles: GoAir IPO | Seaborne Logistics IPO | Seven Islands Shipping IPO | Arohan Financial Services IPO | Exxaro Tiles IPO | India Pesticides IPO | Paras Defence and space technologies IPO | Utkarsh small finance bank IPO | Montecarlo Limited IPO | LIC IPO